Alzheimer Dementia:认知损害的人,黄斑变性的可能性更大

2021-12-08 Freeman MedSci原创

认知障碍与AREDS2中的晚期AMD进展有关,这强调了认知障碍者的眼睛护理的重要性。

年龄相关性黄斑变性(AMD)是一种涉及中央视网膜(黄斑)损伤的眼病,是美国法定失明的最常见原因。2020年,全世界有1.96亿人受到AMD的影响;其中1100万人患有晚期AMD(即晚期AMD,一个疾病阶段,人们也开始出现有症状的视力下降)。

预计到2040年,负担将分别增加到2.88亿人和1900万人。AMD是由环境因素和遗传学之间复杂的相互作用产生的,晚期AMD造成的不可逆的视力丧失会导致生活质量下降和丧失独立性。认知障碍是导致老年人残疾的另一个与年龄有关的原因,通常是渐进的和不可逆的。随着老年人数量的增加,更好地了解导致认知功能损害和痴呆综合症(包括阿尔茨海默病[AD])的风险因素至关重要。

不同强度的证据显示,AD和AMD作为老龄化的神经退行性疾病之间存在关联,但这仍有争议。两者可能在某种程度上共享关键的环境风险因素(如饮食)、组织病理学特征(如淀粉样β[Aβ]的沉积)和病理生理机制(如氧化压力和炎症)。然而,他们的遗传风险状况是不同的;唯一已知的共同基因座是脂蛋白E(APOE)ε4,它与AD的风险增加有关,但可能对发展到晚期AMD有保护作用。


美国国家眼科研究所赞助的老年性眼病研究(AREDS)和AREDS2是多中心、随机临床试验(RCTs),用于治疗AMD和白内障的营养补充剂。AREDS和AREDS2揭示了每日高剂量抗氧化维生素、矿物质和营养素组合的好处,可适度降低从中度到晚期AMD的进展风险。

在AREDS中,调查人员先前记录了AMD和老年人认知障碍之间的潜在联系。这项分析是横断面的,然而AMD和认知障碍之间的关联方向还不清楚。在AREDS2中,调查人员在基线和整个研究访问期间定期测试认知能力,使用的认知功能量表不依赖于需要视觉输入的测试。该试验显示,AREDS2补充剂对认知结果没有影响。

藉此,美国国立卫生研究院的Jimmy T. Le等人,探究了参加AREDS2的中晚期AMD老年人的认知障碍和晚期AMD之间的双向关系。值得注意的是,AREDS2(通过对认知功能的辅助研究和10年的随访21)是最大的老年人研究之一,具有长期随访(中位数为10年)和低随访损失(2%)。

老年性眼病研究2(AREDS2)的参与者每年都要接受眼科检查和认知功能测试(例如,改良的认知状态电话访谈[TICS-M])。他们还研究了认知障碍(如TICS-M得分<30)与5年和10年后的晚期AMD之间的双向关系。

他们分析了5189只眼睛(3157名参与者;平均年龄72.7岁),并对其进行了10.4年的中位跟踪。

与没有认知障碍的参与者相比,基线上有认知障碍的参与者的眼睛在5年(危险比[HR],1.24;95%置信区间[CI],1.08-1.43)和10年(HR,1.20;95%CI,1.05-1.37)更有可能发展成晚期AMD。

基线AMD严重程度较差与发展认知障碍没有关系。

这个研究的重要意义在于发现了:认知障碍与AREDS2中的晚期AMD进展有关,这强调了认知障碍者的眼睛护理的重要性。



原文出处:
Le JT, Agrón E, Keenan TDL, et al. Assessing bidirectional associations between cognitive impairment and late age‐related macular degeneration in the Age‐Related Eye Disease Study 2. Alzheimer’s &amp; Dementia. Published online November 10, 2021:alz.12473. doi:10.1002/alz.12473

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-01-18 12137869m23(暂无昵称)

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-29 ms2000001556510080

    已学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-19 ms2000001757230775

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-13 ms6000001195618985

    受益匪浅

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-13 ms6000001195618985

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-13 MaYazhen

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-11 spiritnsy

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-11 YHW

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1718096, encodeId=42311e180960c, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Thu Aug 25 22:19:23 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185430, encodeId=086e11854308d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220222/09120c6c907546f2833b89808b3b5cb1/5b3e8ffe84c34759b3fa8a8221380b4c.jpg, createdBy=961a2237245, createdName=12137869m23(暂无昵称), createdTime=Tue Jan 18 03:26:01 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085356, encodeId=713d108535642, content=已学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df876430416, createdName=ms2000001556510080, createdTime=Wed Dec 29 09:45:26 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081703, encodeId=09241081e033b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d056397106, createdName=ms2000001757230775, createdTime=Sun Dec 19 08:30:16 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079693, encodeId=5b7e10e969384, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:52:42 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079690, encodeId=69a510e96900c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf55502735, createdName=ms6000001195618985, createdTime=Mon Dec 13 20:51:24 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079429, encodeId=8baa10e942985, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Dec 13 08:51:03 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079133, encodeId=229f10e9133ff, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211121/9ea295fa6f1141baaf5cca7484a33164/749e6341395641abb4881b33ae5e9d68.jpg, createdBy=484e5725266, createdName=spiritnsy, createdTime=Sat Dec 11 22:01:05 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079022, encodeId=1a6510e90228f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4d75638647, createdName=YHW, createdTime=Sat Dec 11 11:37:13 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463783, encodeId=3f4f1463e83a2, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Fri Dec 10 14:19:23 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-10 huangdf

相关资讯

Alzheimer Dementia :痴呆的发生率,或因种族而有所区别

尽管痴呆症的发病率较低,但与白人相比,患有痴呆症的黑人参与者有更多的痴呆症风险因素

Alzheimer Dementia :路易体痴呆患者,核心特征如何随时间变化

男性、RBD和无新皮层缠结的路易体病与可能的DLB的较早潜伏期有关。

Alzheimer Dementia:漂泊无依的人,痴呆风险更高

据估计7%的退伍军人患有阿尔茨海默病(AD)和与AD相关的痴呆症(AD/ADRD)。患有脑外伤和创伤后应激障碍的退伍军人的发病率更高。 住房无保障的退伍军人要么直接经历过无家可归,要么由于极端贫困、住

Alzheimer Dementia :遗传性痴呆,认知减退速度各有不同

在症状出现后,年轻的ADADMCs下降得更快

Alzheimer Dementia : 磷酸化tau蛋白,比总tau蛋白和神经丝轻链更能预测痴呆

血浆p-tau181用于检测AD痴呆,以及使用基于血液的生物标志物进行最佳疾病检测。

Alzheimer Dementia:认知和步态功能越弱,痴呆风险越高

MCR可能代表了一种痴呆症前综合征,其特征是突出的白质异常和额叶萎缩。

拓展阅读

JAMA Neurol:深度睡眠明显减缓大脑衰老,显著降降低痴呆风险

结果表明,每年深度睡眠每减少1%,与患痴呆症的风险增加27%相关,深度睡眠不足可能是一个可改变的痴呆风险因素。

Lecanemab治疗AD获FDA完全批准上市

Lecanemab最初由卫材和BioArctic联合开发,它与β淀粉样蛋白的可溶性寡聚体特异性结合。在AD患者大脑中,β淀粉样蛋白的水平升高会促使它们从单体聚集成为二聚体和可溶性寡

BMC Medicine:贾建平团队首次发现AD新致病基因ZDHHC21突变

该研究在一个AD家系中鉴定出ZDHHC21基因的一个变异位点(C.9A>T,p.T209S)并预测有很强的致病性。

Neurology:陆林院士团队发现各类日常活动与痴呆风险之间的关联

与不参加休闲活动的受试者相比,参加休闲活动的受试者患全因性痴呆的风险降低了17%,患阿尔茨海默病的风险降低了18%,患血管性痴呆的风险降低了32%。

Alz Res Therapy: 额颞叶痴呆,其症状表现和疾病负担有何关联?

DLB症状学和疾病负担之间存在临床相关的联系

Alzheimers Dementia:巴西的全国痴呆风险如何,对中国有何启示?

其他国家,65岁以下人群的痴呆症发病率更高。

2022 欧洲共识:MCI和轻度痴呆初级阶段的诊断和治疗

意大利阿尔兹海默病专家组 · 2022-10-09

适合痴呆症患者的急救护理:老年急救护理应用研究网络范围审查和共识会议的结果

急性期后和长期护理学会(AMDA,The Society for Post-Acute and Long-Term Care Medicine) · 2022-08-01

痴呆及阿尔茨海默病进展要点简析

四川大学华西医院 · 2022-07-26